Encephalomyelitis-Influenza Vaccine, Eastern & Western Killed Virus, Tetanus Toxoid

Description: A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Encephalomyelitis Virus, Eastern and Western, Equine Influenza Virus subtypes A1 and A2 including KY 93 strain, and Tetanus Toxoid. Intervet serological data suggest cross protection against certain U.S. and European strains, including Prague 56, KY 63, KY 81 and 87, Fountainbleau 79, and Berlin 84 and 89.
Neomycin, polymyxin B and nystatin added as preservatives.
Indications: For vaccination of healthy horses against Eastern and Western Equine Encephalomyelitis, Equine Influenza Virus and Tetanus.
Dosage and Administration: For primary immunization, aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. A 1mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.
Precaution(s): Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened.
Caution(s): Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Injury should be followed by a booster dose of vaccine containing Tetanus Toxoid. Consult your veterinarian regarding indications and precautions for the use of Tetanus Antitoxin. Anaphylactoid reactions may occur.
For use in animals only.
Antidote(s): Epinephrine.
Warning(s): Do not vaccinate within 21 days before slaughter.